HearLore
ListenSearchLibrary

Follow the threads

Every story connects to a hundred more

Terms of service·Privacy policy

2026 HearLore

Preview of HearLore

Sign up to follow every thread. No dead ends.

LSD

On the 16th of November 1938, Swiss chemist Albert Hofmann synthesized a new compound while searching for a respiratory stimulant derived from ergot fungus, a grain-infecting mold. This molecule, which he named lysergic acid diethylamide or LSD, was the 25th in a series of lysergamides he created, yet it appeared inert and useless at the time. Five years later, on the 19th of April 1943, Hofmann accidentally absorbed a small amount of the substance through his fingertips while working in his laboratory. He experienced a state of intoxication so profound that he could not remain at work and had to be taken home by bicycle. Upon arriving, he found himself in a dreamlike state where the world around him appeared to be in constant motion, with objects seeming to breathe and shift colors. This accidental ingestion revealed the true power of the molecule, which Hofmann would later describe as a problem child that demanded attention. The following day, he intentionally ingested 250 micrograms of the substance to confirm his findings, experiencing what he called a "fantastic play of colors" and a sense of being transported to another reality. This event marked the beginning of the psychedelic era, transforming a chemical curiosity into a substance that would redefine human consciousness.

The Golden Age of Psychiatry

In the 1950s, LSD became the most widely studied drug in the history of psychiatry, with Sandoz Laboratories distributing it freely to researchers under the trade name Delysid. The drug was hailed as a panacea, with early studies suggesting it could cure everything from schizophrenia to alcoholism and even correct sexual perversions. Psychiatrists like Humphry Osmond pioneered the use of LSD to treat alcoholism, coining the term "psychedelic" to describe mind-manifesting experiences that transcended the previous "psychotomimetic" model which viewed the drug as merely mimicking schizophrenia. The Central Intelligence Agency, however, had a different agenda, launching Project MKUltra in 1953 to explore the potential of LSD for mind control and interrogation. The agency purchased the entire world supply of LSD for $240,000 and distributed it to hospitals, prisons, and research centers, often administering it to unwitting subjects including CIA employees, military personnel, and prostitutes. One of the most notorious experiments, Operation Midnight Climax, involved setting up brothels where unsuspecting women were drugged with LSD and observed through one-way mirrors. Despite the initial enthusiasm, the quality of early research was often poor, lacking control groups and rigorous methodology. By 1975, a congressional report concluded that LSD showed little difference from placebo for most conditions, yet the drug had already left an indelible mark on the field of mental health.

The Counterculture Revolution

Continue Browsing

1938 in science1938 in Switzerland1938 introductions5-HT1A agonists5-HT2A agonists5-HT2B agonists5-HT2C agonistsArticles containing video clipsBiased ligandsCounterculture of the 1960sDiethylamino compoundsDopamine agonistsDrugs developed by NovartisEnantiopure drugsEntheogensExperimental hallucinogensIncapacitating agentsLight-sensitive chemicalsMind controlPsychedelic lysergamidesPsychedelic-assisted therapyPsychoplastogensSerotonin receptor agonists
By the mid-1960s, LSD had become the central symbol of the youth counterculture movement, particularly in San Francisco and London. The drug was no longer just a psychiatric tool but a catalyst for social change, influencing art, music, and political activism. Owsley Stanley, a chemist and member of the Grateful Dead, established the first major underground LSD factory, producing high-purity acid that fueled the psychedelic scene. The Merry Pranksters, led by novelist Ken Kesey, organized the Acid Tests, events where LSD was consumed alongside light shows and improvised music, creating a communal experience that challenged societal norms. In the Haight-Ashbury neighborhood, the Psychedelic Shop opened in January 1966 to promote the safe use of LSD, while Michael Hollingshead founded the World Psychedelic Center in London to spread the message of consciousness expansion. Figures like Aldous Huxley, Timothy Leary, and Alan Watts advocated for the use of psychedelics to expand human awareness, influencing a generation of youth who saw the drug as a means to transcend the limitations of everyday consciousness. The cultural impact was profound, with bands like the Grateful Dead, Jefferson Airplane, and the Beatles incorporating psychedelic themes into their music and art. The drug became synonymous with the counterculture movement, leading to its eventual criminalization as a threat to American values and the Vietnam War effort.

The Legal Crackdown

The association of LSD with the counterculture movement led to a swift and severe legal backlash, culminating in its classification as a Schedule I controlled substance in the United States in 1970. This designation, which deemed the drug to have a high potential for abuse and no legitimate medical use, effectively ended its legal availability for research and therapy. The United Nations followed suit in 1971, listing LSD as a Schedule I controlled substance globally. The last FDA-approved study of LSD in patients ended in 1980, and a study in healthy volunteers was conducted in the late 1980s, marking the end of an era of scientific exploration. Despite these restrictions, LSD remained a potent symbol of rebellion, with its use continuing underground. The legal status of the drug has been a subject of debate for decades, with some arguing that its Schedule I classification has hindered potential medical breakthroughs. In recent years, there has been a resurgence of interest in LSD, with the U.S. Food and Drug Administration designating it as a breakthrough therapy for generalized anxiety disorder in 2024. Oregon became the first U.S. state to decriminalize possession of small amounts of LSD in 2021, signaling a shift in public opinion and a potential return to the drug's therapeutic roots.

The Science of Consciousness

LSD exerts its effects primarily through high-affinity binding to serotonin receptors, particularly the 5-HT2A receptor, which is responsible for the drug's psychedelic properties. The molecule's unique structure allows it to bind to these receptors with exceptional strength, leading to a prolonged residence time that accounts for the drug's long duration of action. Neuroimaging studies have shown that LSD reduces oscillatory power in the brain's default mode network, flattening the brain's hierarchy and allowing for increased connectivity between different regions. This change in cortical functional architecture is thought to be responsible for the drug's ability to induce altered states of consciousness, including visual and auditory hallucinations, ego dissolution, and mystical experiences. The drug's effects are not limited to the 5-HT2A receptor, as it also interacts with dopamine and adrenergic receptors, contributing to its complex pharmacological profile. Despite its potency, LSD is considered physiologically safe at standard doses, with no documented fatal human overdoses. The drug's safety profile has led to renewed interest in its potential therapeutic applications, particularly for treating conditions such as depression, anxiety, and addiction. Research continues to explore the mechanisms by which LSD produces its effects, with the goal of developing new treatments that harness the drug's unique properties without the risks associated with its recreational use.
On the 16th of November 1938, Swiss chemist Albert Hofmann synthesized a new compound while searching for a respiratory stimulant derived from ergot fungus, a grain-infecting mold. This molecule, which he named lysergic acid diethylamide or LSD, was the 25th in a series of lysergamides he created, yet it appeared inert and useless at the time. Five years later, on the 19th of April 1943, Hofmann accidentally absorbed a small amount of the substance through his fingertips while working in his laboratory. He experienced a state of intoxication so profound that he could not remain at work and had to be taken home by bicycle. Upon arriving, he found himself in a dreamlike state where the world around him appeared to be in constant motion, with objects seeming to breathe and shift colors. This accidental ingestion revealed the true power of the molecule, which Hofmann would later describe as a problem child that demanded attention. The following day, he intentionally ingested 250 micrograms of the substance to confirm his findings, experiencing what he called a "fantastic play of colors" and a sense of being transported to another reality. This event marked the beginning of the psychedelic era, transforming a chemical curiosity into a substance that would redefine human consciousness.

The Golden Age of Psychiatry

In the 1950s, LSD became the most widely studied drug in the history of psychiatry, with Sandoz Laboratories distributing it freely to researchers under the trade name Delysid. The drug was hailed as a panacea, with early studies suggesting it could cure everything from schizophrenia to alcoholism and even correct sexual perversions. Psychiatrists like Humphry Osmond pioneered the use of LSD to treat alcoholism, coining the term "psychedelic" to describe mind-manifesting experiences that transcended the previous "psychotomimetic" model which viewed the drug as merely mimicking schizophrenia. The Central Intelligence Agency, however, had a different agenda, launching Project MKUltra in 1953 to explore the potential of LSD for mind control and interrogation. The agency purchased the entire world supply of LSD for $240,000 and distributed it to hospitals, prisons, and research centers, often administering it to unwitting subjects including CIA employees, military personnel, and prostitutes. One of the most notorious experiments, Operation Midnight Climax, involved setting up brothels where unsuspecting women were drugged with LSD and observed through one-way mirrors. Despite the initial enthusiasm, the quality of early research was often poor, lacking control groups and rigorous methodology. By 1975, a congressional report concluded that LSD showed little difference from placebo for most conditions, yet the drug had already left an indelible mark on the field of mental health.

The Counterculture Revolution

By the mid-1960s, LSD had become the central symbol of the youth counterculture movement, particularly in San Francisco and London. The drug was no longer just a psychiatric tool but a catalyst for social change, influencing art, music, and political activism. Owsley Stanley, a chemist and member of the Grateful Dead, established the first major underground LSD factory, producing high-purity acid that fueled the psychedelic scene. The Merry Pranksters, led by novelist Ken Kesey, organized the Acid Tests, events where LSD was consumed alongside light shows and improvised music, creating a communal experience that challenged societal norms. In the Haight-Ashbury neighborhood, the Psychedelic Shop opened in January 1966 to promote the safe use of LSD, while Michael Hollingshead founded the World Psychedelic Center in London to spread the message of consciousness expansion. Figures like Aldous Huxley, Timothy Leary, and Alan Watts advocated for the use of psychedelics to expand human awareness, influencing a generation of youth who saw the drug as a means to transcend the limitations of everyday consciousness. The cultural impact was profound, with bands like the Grateful Dead, Jefferson Airplane, and the Beatles incorporating psychedelic themes into their music and art. The drug became synonymous with the counterculture movement, leading to its eventual criminalization as a threat to American values and the Vietnam War effort.

The Legal Crackdown

The association of LSD with the counterculture movement led to a swift and severe legal backlash, culminating in its classification as a Schedule I controlled substance in the United States in 1970. This designation, which deemed the drug to have a high potential for abuse and no legitimate medical use, effectively ended its legal availability for research and therapy. The United Nations followed suit in 1971, listing LSD as a Schedule I controlled substance globally. The last FDA-approved study of LSD in patients ended in 1980, and a study in healthy volunteers was conducted in the late 1980s, marking the end of an era of scientific exploration. Despite these restrictions, LSD remained a potent symbol of rebellion, with its use continuing underground. The legal status of the drug has been a subject of debate for decades, with some arguing that its Schedule I classification has hindered potential medical breakthroughs. In recent years, there has been a resurgence of interest in LSD, with the U.S. Food and Drug Administration designating it as a breakthrough therapy for generalized anxiety disorder in 2024. Oregon became the first U.S. state to decriminalize possession of small amounts of LSD in 2021, signaling a shift in public opinion and a potential return to the drug's therapeutic roots.

The Science of Consciousness

LSD exerts its effects primarily through high-affinity binding to serotonin receptors, particularly the 5-HT2A receptor, which is responsible for the drug's psychedelic properties. The molecule's unique structure allows it to bind to these receptors with exceptional strength, leading to a prolonged residence time that accounts for the drug's long duration of action. Neuroimaging studies have shown that LSD reduces oscillatory power in the brain's default mode network, flattening the brain's hierarchy and allowing for increased connectivity between different regions. This change in cortical functional architecture is thought to be responsible for the drug's ability to induce altered states of consciousness, including visual and auditory hallucinations, ego dissolution, and mystical experiences. The drug's effects are not limited to the 5-HT2A receptor, as it also interacts with dopamine and adrenergic receptors, contributing to its complex pharmacological profile. Despite its potency, LSD is considered physiologically safe at standard doses, with no documented fatal human overdoses. The drug's safety profile has led to renewed interest in its potential therapeutic applications, particularly for treating conditions such as depression, anxiety, and addiction. Research continues to explore the mechanisms by which LSD produces its effects, with the goal of developing new treatments that harness the drug's unique properties without the risks associated with its recreational use.
Swiss inventions
TAAR1 modulators
TiHKAL
Wikipedia medicine articles ready to translate